Abstract
Dose Adjustment During Pollen Seasons in Build-up and Maintenance Vials Lowers the Risk of Severe Systemic Reactions (SRs) to Subcutaneous Allergen Immunotherapy (SCIT): Year 4 of the AAAAI/ACAAI Surveillance Study
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
